
While reducing the risk of classic fracture, treatment with bisphosphonates may increase the risk of atypical fractures of the femur, with a longer duration of treatment linked to this increasing risk, according to a new study. “We have demonstrated that the association between bisphosphonate treatment and the occurrence of atypical…
Read more »
Menopausal hormone replacement therapy reduces fractures but increases risks for other conditions
A great deal of controversy surrounds the use of menopausal hormone replacement therapy (HRT) for the prevention of chronic conditions. “There are robust data now coming in that there is a window of opportunity in the early menopausal years when HRT may reduce the risk of cardiovascular disease. It would…
Read more »